Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc. (Details)

v3.20.1
Net Loss Per Share - Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc. (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net Loss Per Share    
Net loss $ (6,373,420) $ (5,819,081)
Net loss: Non-controlling interest (81,314) (103,605)
Net loss attributable to Heat Biologics, Inc. $ (6,292,106) $ (5,715,476)
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.-basic and diluted 57,282,075 33,225,164
Net loss per share applicable to Heat Biologics, Inc - basic and diluted $ (0.11) $ (0.17)